INVESTOR ALERT: Investigation of Hanger, Inc. Announced by Glancy Binkow & Goldberg LLP

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Hanger, Inc. (“Hanger” or the “Company”) (NYSE:HGR) concerning possible violations of federal securities laws. The investigation is focused on certain statements issued by Hanger between August 1, 2013 and August 7, 2014, concerning the Company’s operations and financial performance; specifically, the Company's accounting for its reserves for accounts receivable and bad debt.

Please contact Casey Sadler, at (310) 201-9150, or at shareholders@glancylaw.com to discuss this matter. If you inquire by email, please include your mailing address, telephone number and number of shares purchased.

Hanger provides orthotic and prosthetic (O&P) patient care services, distributes O&P devices and components, manages O&P networks and offers therapeutic solutions in the United States. The investigation is related to the Company’s August 7, 2014, announcement that Hanger’s earnings per share decreased approximately 23% and the Company anticipated lower earnings per share than previously estimated for fiscal 2014, due to an increase in audits of its Medicare reimbursement claims.

The Company further announced that its accounts receivable over 120 days had increased by $14 million year-over-year, due to increased Medicare audits, and that the Company’s operating costs had increased $8 million for the year, $4.2 million of which was attributable to an increase in bad debt. Following this news, Hanger shares declined 25%, or $7.39 per share, to close at $22.48 per share on August 8, 2014, on unusually heavy volume.

If you purchased Hanger shares between August 1, 2013 and August 7, 2014, if you have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Casey Sadler, Esquire, of Glancy Binkow & Goldberg LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at (310) 201-9150, Toll Free at (888) 773-9224, by e-mail to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.